Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Progenity Inc (PROG)

Progenity Inc (PROG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Progenity Announces Successful Transfer of Liquid Biopsy Technologies Globe Newswire - Thu May 5, 2022

Enumera Molecular Formed to Develop and Commercialize Next-Generation Solutions for Liquid Biopsy...

PROG : 0.8845 (-3.47%)
Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s Ingestible Drug/Device Platforms Globe Newswire - Mon Apr 25, 2022

Expanding Leadership Team to Accelerate Development of Innovative Therapeutic Delivery Platforms...

PROG : 0.8845 (-3.47%)
Progenity to Become Biora Therapeutics as it Completes Transformation Globe Newswire - Tue Apr 12, 2022

Upcoming Change Reflects the Company’s Focus on Oral Delivery of Biotherapeutics...

PROG : 0.8845 (-3.47%)
Progenity Announces Two Poster Presentations at Controlled Release Society 2022 Globe Newswire - Wed Apr 6, 2022

SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for...

PROG : 0.8845 (-3.47%)
Stocks-Money-Rates - Stock Chart Black and White
U.S. Stock Indexes Jump on Cease-Fire Optimism in Ukraine Barchart - Tue Mar 29, 2022

Morning Markets June S&P 500 futures this morning rallied to a 2-1/4 month high and are up by +0.87%. Stock indexes pushed higher this morning on optimism about progress in cease-fire talks between Russia...

BTBT : 2.22 (+1.37%)
JEF : 44.59 (+2.44%)
DNA : 0.8705 (+3.29%)
REYN : 28.63 (+1.35%)
CVS : 68.50 (-1.62%)
PLAY : 56.13 (+2.84%)
PROG : 0.8845 (-3.47%)
PINS : 33.02 (+0.89%)
ETSY : 68.35 (+2.86%)
Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results Globe Newswire - Mon Mar 28, 2022

Accelerated Company Transformation Toward Oral Delivery of Biotherapeutics and Targeted Therapeutics Programs Progressed Company’s Targeted Therapeutics...

PROG : 0.8845 (-3.47%)
Interesting PROG Put And Call Options For May 20th Dividend Channel - Mon Mar 28, 2022

Investors in Progenity Inc saw new options begin trading this week, for the May 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PROG options chain for the...

PROG : 0.8845 (-3.47%)
Jobs Figures Due Friday in U.S. Baystreet - Fri Mar 25, 2022

Monday U.S. Featured Earnings Jefferies Financial Group Inc. (NYSE:JEF) (Q1) EPS estimates ...

LAS-A.TO : 144.00 (-0.10%)
MRV.TO : 1.35 (unch)
DLCG.TO : 3.02 (unch)
JEF : 44.59 (+2.44%)
SAIC : 128.08 (+2.36%)
PROG : 0.8845 (-3.47%)
MU : 112.46 (+3.06%)
LULU : 364.68 (+0.80%)
MKC : 75.02 (+0.44%)
PAYX : 121.62 (+0.32%)
AER : 86.13 (+2.04%)
WBA : 18.05 (-0.93%)
Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update Globe Newswire - Wed Mar 16, 2022

SAN DIEGO, March 16, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for...

PROG : 0.8845 (-3.47%)
Progenity Progresses its Drug Delivery System Clinical Device Performance Studies Globe Newswire - Thu Mar 10, 2022

Clinical Device Performance Study in Healthy Volunteers Demonstrated Accurate Localization and Delivery A Clinical Device Performance Study in Patients...

PROG : 0.8845 (-3.47%)

Barchart Exclusives

Should You Buy This Beaten-Down AI Stock for Its 4% Dividend Yield? Barchart - Tue Apr 23, 6:30PM CDT
Sales of AI-enabled gadgets are expected to drive hardware sales over the next few years. PC maker HP looks like an AI play worth buying for its nearly 4% dividend yield and tepid valuations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot